Gilead’s Harvoni overtakes Sovaldi in hepatitis C market

Harvoni accounted for about 75% of the 48,000 prescriptions per month filled for hepatitis C drugs in the first 3 months of the year – even though Sovaldi costs $1,000/pill and Harvoni $1,350/pill.